| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2000 | US6096543 Antisense inhibition of human mek1 expression |
| 08/01/2000 | US6096542 Cancer control |
| 08/01/2000 | US6096539 Protein activator of apoptosis |
| 08/01/2000 | US6096527 Nucleic acids encoding protein tryosine kinases |
| 08/01/2000 | US6096526 Amino acid sequences; for diagnosis, treatment and prevention of cancer and developmental disorders; anticarcinogenic agents; antagonists; agonists; antibodies; hybridization probes; recombinant production of enzyme |
| 08/01/2000 | US6096522 Antibody and method for detecting the human homolog of MAD2 |
| 08/01/2000 | US6096521 Adhesin from Helicobacter pylori |
| 08/01/2000 | US6096520 Brain glycogen phosphorylase cancer antigen |
| 08/01/2000 | US6096519 Chlamydia trachomatis serotype D proteins |
| 08/01/2000 | US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides |
| 08/01/2000 | US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related |
| 08/01/2000 | US6096514 Human calcium channel compositions and methods |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096335 Stable particulate complexes having a lamellar, rolled, and condensed structure |
| 08/01/2000 | US6096323 Vaccine against papillomatous digital dermatitis (PDD) |
| 08/01/2000 | US6096319 Peptides with amino acid sequences |
| 08/01/2000 | US6096318 Antigenically modified HCG polypeptides |
| 08/01/2000 | US6096315 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 08/01/2000 | US6096314 Peptides and pharmaceutical compositions comprising them |
| 08/01/2000 | US6096313 Immunology using peptides of amino acid sequences |
| 08/01/2000 | US6096312 Agent for suppressing a reduction of CD4+ lymphocytes |
| 08/01/2000 | US6096311 Methods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin G |
| 08/01/2000 | US6096309 Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096307 Immunology for bacteria and viruses |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | US6096303 Method to enhance treatment of cystic tumors |
| 08/01/2000 | US6096301 Combined interferon/antiestrogen therapy for treatment of breast cancer |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 08/01/2000 | CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2149209C Use of topically applied factor xiii for inhibiting hemorrhage |
| 08/01/2000 | CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/01/2000 | CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 08/01/2000 | CA2123786C Method of treating viral infections with c-reactive protein |
| 08/01/2000 | CA2099976C Repressors of the trans-activating function of papillomavirus e2 proteins |
| 08/01/2000 | CA2024651C High-absorbable transvaginal preparation containing biologically active polypeptide |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 08/01/2000 | CA2005714C Transdermal estrogen/progestin dosage unit, system and process |
| 08/01/2000 | CA1341070C Pulmonary surfactant protein and related polypeptide |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 08/01/2000 | CA1341064C Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions |
| 07/29/2000 | CA2291962A1 Glucose regulated gene |
| 07/29/2000 | CA2258973A1 Glucose regulated gene |
| 07/28/2000 | CA2297464A1 Pharmaceutical preparation for the treatment of inflammatory processes |
| 07/28/2000 | CA2296311A1 Enzymatic hydrolysate of milk proteins |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043549A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | WO2000043548A1 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043524A1 Polypeptides derived from jnk3 |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043514A2 Human acid sensing ion channel and uses thereof |
| 07/27/2000 | WO2000043512A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | WO2000043508A2 Cancer-associated proteins |
| 07/27/2000 | WO2000043505A2 Protease with two aspartate radicals in the catalytically active structure |
| 07/27/2000 | WO2000043503A1 Improved phytases |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043493A2 Metalloproteinase adam 22 |
| 07/27/2000 | WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043418A1 Bira |
| 07/27/2000 | WO2000043417A1 Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043409A2 Alpha-conotoxin peptides |
| 07/27/2000 | WO2000043403A1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes |
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043048A1 Treating protein-containing liquids |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000043037A2 Hiv-encoded chemoattractant |
| 07/27/2000 | WO2000043036A2 Lipoprotein complexes and compositions containing them |
| 07/27/2000 | WO2000043035A1 Amino acid-containing albumin preparations |
| 07/27/2000 | WO2000043034A2 Monodisperse hexameric acylated insulin analog formulations |
| 07/27/2000 | WO2000043033A1 CHAPERONIN 10 AND β-INTERFERON THERAPY OF MULTIPLE SCLEROSIS |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043031A1 Tumor necrosis factor antagonists and their use in endometriosis |
| 07/27/2000 | WO2000043030A1 Method of suppressing ongoing acute allograff rejection |
| 07/27/2000 | WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | WO2000043028A2 Method of treating chronic cardiac disease |
| 07/27/2000 | WO2000043027A1 Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease |
| 07/27/2000 | WO2000043026A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 07/27/2000 | WO2000043013A1 Pharmaceutical compositions for alleviating discomfort |
| 07/27/2000 | WO2000043000A1 Proteasome inhibitors |
| 07/27/2000 | WO2000042993A2 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
| 07/27/2000 | WO2000042982A1 Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
| 07/27/2000 | WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | WO2000042972A2 Compositions and methods for intraductal gene therapy |
| 07/27/2000 | WO2000042868A1 Infant formula |
| 07/27/2000 | WO2000042863A1 A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
| 07/27/2000 | WO2000042856A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |